首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Measurement and evaluation of inhomogeneity corrections and monitor unit verification for treatment planning.
【24h】

Measurement and evaluation of inhomogeneity corrections and monitor unit verification for treatment planning.

机译:测量和评估不均匀性校正并监控治疗计划的单位验证。

获取原文
获取原文并翻译 | 示例
           

摘要

Heterogeneous lung and bone phantoms have been constructed for the purpose of testing monitor unit calculations at or near interfaces for different planning systems. Data have been acquired for 2 linear accelerators: a Varian 2300cd (6 and 25 MV) and an Elekta Synergy (6, 10, and 18 MV). We have reviewed Pinnacle and the correction-based, pre-AAA version of Eclipse planning systems with the intent of exploring the limits of these systems with energy and field size. Data were acquired from 2 x 2 to 10 x 10 cm(2) field sizes over the available range of energies. Our measurements confirm that Pinnacle predicts doses mostly to within +/- 5%, even near lung-tissue interfaces over the full range of energies and field sizes tested. The Eclipse-modified Batho and equivalent TMR algorithms overpredicted doses by 10% or more in the lung and near the lung-tissue interfaces if the field size was less than 10 x 10 cm(2) when the energy was 18 MV or higher. At lower energies, the field size had to be at least 6 x 6 cm(2) for calculated doses to be within 10% of measurement. For bone-tissue interfaces, doses were generally underestimated by 5% to 10% or more by all calculation methods over the range of field sizes and energies reviewed. A second goal of this study was to review methods for hand-checking monitor units when heterogeneities are included. We evaluated the range of applicability of 2, one-dimensional (1D) inhomogeneity correction factors: the effective attenuation method and the TMR ratio method. The effective attenuation method for monitor unit checking was within +/- 5% to as small as 6 x 6 cm(2) fields for 6 to 10 MV, usable for 4 x 4 cm(2) fields (within 7%) for 6 MV and close to +/- 5% for 10 x 10 cm(2) fields in the 18- to 25-MV range. The TMR ratio method was not as good, being within about +/- 5% to 7% of measurements only for 6 x 6 to 10 x 10 cm(2) fields at 6 MV and 10 x 10 cm(2) fields at the higher energies. Both simple 1D correction methods performed almost as well as Pinnacle for the bone-soft tissue cases. We recommend that if direct measurement of dose for heterogeneous treatment plans is not practiced, then one of these simple cross checks be performed to assure patient safety.
机译:为了测试在不同计划系统的界面处或界面附近的监控器单元计算,已经构建了异构的肺部和骨骼幻像。已获得2种线性加速器的数据:Varian 2300cd(6和25 MV)和Elekta Synergy(6、10和18 MV)。我们已经审查了Pinnacle和基于校正的AAA规划之前的Eclipse规划系统版本,以期探索这些系统在能量和字段大小方面的局限性。在可用能量范围内,从2 x 2到10 x 10 cm(2)的场大小获取数据。我们的测量结果证实,品尼高预测的剂量大多在+/- 5%之内,甚至在所测试的整个能量范围和视野范围内,甚至接近肺组织界面。如果当能量为18 MV或更高时视野大小小于10 x 10 cm(2),则Eclipse修改过的Batho和等效的TMR算法在肺部和肺组织界面附近的剂量会高估10%或更多。在较低的能量下,计算出的剂量必须在测量值的10%以内,视野大小必须至少为6 x 6 cm(2)。对于骨组织界面,在所查看的视野大小和能量范围内,所有计算方法通常将剂量低估5%至10%或更多。这项研究的第二个目标是审查包括异质性在内的人工检查监测单元的方法。我们评估了2个一维(1D)非均匀性校正因子的适用范围:有效衰减方法和TMR比方法。用于监视单元检查的有效衰减方法在6到10 MV的+/- 5%范围内,小至6 x 6 cm(2)视场,对于6视场可用于4 x 4 cm(2)视场(7%内) MV,在18至25-MV范围内的10 x 10 cm(2)场接近+/- 5%。 TMR比率方法不是很好,仅在6 MV时6 x 6至10 x 10 cm(2)场和10 x 10 cm(2)场的测量值的大约+/- 5%至7%之内更高的能量。两种简单的一维校正方法的效果几乎都与品骨软组织的Pinnacle一样。我们建议,如果未对异类治疗计划进行直接剂量测量,则应执行这些简单的交叉检查之一以确保患者安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号